Smith & Nephew Healthcare Ltd.
GPTKB entity
Statements (76)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
gptkb:Blue_Belt_Technologies
Acquired the wound care division of Covidien. Acquired_the_orthopedic_business_of_Bioventus. KCI_Medical Tissue_Regenix_Group_plc Wound_Care_business_of_Acelity |
gptkbp:awards |
Recognized for innovation in healthcare
|
gptkbp:brand |
Well-known brand in the healthcare industry.
|
gptkbp:CEO |
Deepak_Nath
|
gptkbp:clinicalTrials |
Conducts clinical trials for product efficacy
Involved in numerous clinical research studies. |
gptkbp:communityEngagement |
Active in community health initiatives
|
gptkbp:communitySupport |
Supports local communities through various initiatives.
|
gptkbp:competitors |
gptkb:Johnson_&_Johnson
gptkb:Medtronic Stryker Corporation Zimmer Biomet |
gptkbp:corporateSocialResponsibility |
Engages in various CSR initiatives.
|
gptkbp:customerBase |
Serves hospitals, clinics, and healthcare providers.
|
gptkbp:customerFeedback |
Values customer feedback for product improvement.
|
gptkbp:employees |
around 18,000
Promotes employee engagement and satisfaction. |
gptkbp:environmentalImpact |
Works to reduce environmental impact.
|
gptkbp:expansion |
Expanded_into_the_US_market_in_the_20th_century.
|
gptkbp:financialPerformance |
Consistent revenue growth over the years.
|
gptkbp:financials |
Demonstrates financial stability.
Publicly traded company with regular financial disclosures. |
gptkbp:focus |
Innovative medical solutions
|
gptkbp:focusArea |
Orthopedic and wound care solutions
|
gptkbp:founded |
1856
|
gptkbp:founder |
gptkb:Thomas_Smith
|
gptkbp:futurePlans |
Plans for future growth and expansion.
|
gptkbp:globalPresence |
Over 100 countries
|
gptkbp:headCoach |
Approximately 18,000 employees globally
|
gptkbp:headquarters |
gptkb:London,_United_Kingdom
|
gptkbp:healthcare |
Leads in healthcare innovation.
|
gptkbp:history |
Founded in 1856 in Sheffield, England.
|
https://www.w3.org/2000/01/rdf-schema#label |
Smith & Nephew Healthcare Ltd.
|
gptkbp:industry |
Medical Devices
|
gptkbp:innovation |
Focus on minimally invasive surgical techniques.
|
gptkbp:investmentFocus |
Maintains active communication with investors.
|
gptkbp:localGovernment |
Adheres to high standards of corporate governance.
|
gptkbp:manufacturer |
Located in London, UK.
|
gptkbp:market |
$10 billion (2022)
Adapts to changing market trends. Strong position in the global medical device market. |
gptkbp:marketingStrategy |
Commits to ethical business practices.
Operates in multiple business segments. |
gptkbp:marketSegment |
Emphasizes on strategic partnerships and acquisitions.
|
gptkbp:merchandise |
Sales in over 100 countries.
|
gptkbp:partnerships |
Various healthcare organizations
Collaborates with universities for research. Collaborates with healthcare professionals for product development. |
gptkbp:patentCitation |
Numerous patents in medical technology
|
gptkbp:philosophy |
Patient-centered approach to healthcare.
|
gptkbp:productLine |
Includes joint reconstruction, wound management, and sports medicine.
|
gptkbp:products |
Trauma
Sports Medicine Focus on innovative product development. Orthopedic Reconstruction Prioritizes product safety and efficacy. Advanced_Wound_Management |
gptkbp:R&D |
Significant investment in research and development
|
gptkbp:regulatoryCompliance |
Complies with international medical device regulations.
|
gptkbp:researchFocus |
Focus on regenerative medicine.
|
gptkbp:revenue |
$5 billion (2022)
|
gptkbp:stockExchange |
gptkb:London_Stock_Exchange
|
gptkbp:stockSymbol |
SN.
|
gptkbp:strategicGoals |
Focus on growth and innovation.
|
gptkbp:subsidiary |
Smith_&_Nephew_(Ireland)_Ltd.
Smith_&_Nephew_Inc. |
gptkbp:supplyChain |
Global supply chain network.
|
gptkbp:sustainability |
Commitment to sustainable practices
|
gptkbp:training |
Offers extensive training programs for employees.
|
gptkbp:website |
www.smith-nephew.com
|